Emrok O Tablet Substitute


Composition:
LEVONADIFLOXACIN-500MG
Uses:
<p>Emrok O Tablet is used in the treatment of Bacterial skin and soft tissue infections. The detailed uses of Emrok O Tablet are as follows:</p><ul><li><strong>Treat acute bacterial skin and skin structure infections:</strong> Emrok O Tablet is used to manage serious skin infections, including cellulitis and diabetic foot infections, especially those caused by resistant Gram-positive bacteria like MRSA.</li><li><strong>Manage respiratory tract infections:</strong> Emrok O Tablet helps treat bacterial pneumonia, bronchitis, and other upper and lower respiratory infections caused by susceptible organisms.</li><li><strong>Treat urinary tract infections (UTIs):</strong> Emrok O Tablet is effective against bacteria responsible for UTIs, including strains resistant to other antibiotics.</li><li><strong>Control bone and joint infections:</strong> Emrok O Tablet is used in the treatment of osteomyelitis and septic arthritis by targeting deep-seated bacterial infections.</li></ul>
Medicinal Benefits:
Emrok O Tablet contains 'Levonadifloxacin,' a broad-spectrum anti-MRSA agent that treats bacterial skin and soft tissue infections, including diabetic foot infections and concurrent bacteraemia. It is a fluoroquinolone antibiotic and is bactericidal in action. It works by inhibiting beta-lactamase, the enzyme produced by the bacteria, which inactivates the antibiotic, leading to multi-resistance.
Emrok O Tablet belongs to the class of antibiotics used in the treatment of bacterial skin and soft tissue infections, including diabetic foot infections and concurrent bacteraemia (presence of viable bacteria in the bloodstream).
Emrok O Tablet contains Levonadifloxacin which works by interfering with bacterial replication and preventing the growth of the bacteria causing major skin infections.
Emrok O Tablet may cause constipation. Drink lots of fluids and eat fibre-rich food if you experience constipation. If the condition persists or worsens, consult your doctor.
Emrok O Tablet is a novel broad-spectrum anti-MRSA benzoquinolizine quinolone agent with potent bactericidal action against gram-positive, quinolone-susceptible gram-negative, anaerobic and atypical bacteria.
Emrok O Tablet may be indicated for treating diabetic foot infections, the most common complication of diabetes mellitus.
Diabetic patients should use Emrok O Tablet only when prescribed by a doctor. This medicine may cause disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia, usually in diabetic patients receiving concomitant treatment with an oral hypoglycaemic agent (like sulphonyl urea) or with insulin. Hence, if you have diabetes and notice symptoms like confusion, dizziness, headache, shakiness, sweating, pounding heart or trembling while using Emrok O Tablet, please contact your doctor immediately.
Take Emrok O Tablet at least 2 hours before or 6 hours after antacids containing magnesium, aluminium, or sucralfate since these components may interfere with the medicine's absorption.
Emrok O Tablet may cause low blood sugar levels and mental health-related side effects; hence, you should take a doctor's advice before starting this medicine.